A. Kandoussi

740 total citations
16 papers, 618 citations indexed

About

A. Kandoussi is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A. Kandoussi has authored 16 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A. Kandoussi's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Advanced Proteomics Techniques and Applications (3 papers). A. Kandoussi is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Advanced Proteomics Techniques and Applications (3 papers). A. Kandoussi collaborates with scholars based in France and Sweden. A. Kandoussi's co-authors include J C Fruchart, Eugen Koren, Pascal Puchois, M Bertrand, Jean L. Fourrier, P. Fievet, Christophe Furman, J.D. Fesmire, Petar Alaupovic and C Cachera and has published in prestigious journals such as Free Radical Biology and Medicine, Kidney International and Clinical Chemistry.

In The Last Decade

A. Kandoussi

16 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Kandoussi France 8 368 353 156 145 122 16 618
Silvia Michelagnoli Italy 9 282 0.8× 322 0.9× 116 0.7× 80 0.6× 109 0.9× 12 492
Gemma Gianfranceschi Italy 14 318 0.9× 320 0.9× 86 0.6× 140 1.0× 141 1.2× 18 635
M. Ishola United Kingdom 11 504 1.4× 507 1.4× 145 0.9× 93 0.6× 188 1.5× 16 850
P Douste‐Blazy France 11 259 0.7× 302 0.9× 110 0.7× 140 1.0× 147 1.2× 27 625
A. Gustafson Sweden 18 399 1.1× 312 0.9× 162 1.0× 177 1.2× 120 1.0× 63 881
Menno Vergeer Netherlands 11 437 1.2× 518 1.5× 164 1.1× 164 1.1× 185 1.5× 15 869
G. J. Miller United Kingdom 5 298 0.8× 264 0.7× 98 0.6× 98 0.7× 125 1.0× 6 505
W R Hazzard United States 10 338 0.9× 392 1.1× 174 1.1× 129 0.9× 134 1.1× 12 682
C. Justin Cooke United Kingdom 10 386 1.0× 476 1.3× 124 0.8× 199 1.4× 114 0.9× 12 906
Afroditi P. Tambaki Greece 12 297 0.8× 471 1.3× 136 0.9× 99 0.7× 143 1.2× 15 793

Countries citing papers authored by A. Kandoussi

Since Specialization
Citations

This map shows the geographic impact of A. Kandoussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Kandoussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Kandoussi more than expected).

Fields of papers citing papers by A. Kandoussi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Kandoussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Kandoussi. The network helps show where A. Kandoussi may publish in the future.

Co-authorship network of co-authors of A. Kandoussi

This figure shows the co-authorship network connecting the top 25 collaborators of A. Kandoussi. A scholar is included among the top collaborators of A. Kandoussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Kandoussi. A. Kandoussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kandoussi, A., Sevser Şahpaz, Olivier Pétrault, et al.. (2006). Tu-P7:140 Paullina pinnata extracts rich in polyphenol promote vascular relaxation via endothelium-dependent mechanisms. Atherosclerosis Supplements. 7(3). 215–216. 1 indexed citations
2.
Furman, Christophe, Anna-Klara Rundlöf, Guilhem Larigauderie, et al.. (2004). Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteins. Free Radical Biology and Medicine. 37(1). 71–85. 47 indexed citations
3.
Martin‐Nizard, Françoise, Christophe Furman, A. Kandoussi, et al.. (2002). Peroxisome Proliferator–activated Receptor Activators Inhibit Oxidized Low-density Lipoprotein–induced Endothelin-1 Secretion in Endothelial Cells. Journal of Cardiovascular Pharmacology. 40(6). 822–831. 76 indexed citations
4.
Massy, Ziad A., A. Kandoussi, Marie‐France Mamzer, et al.. (2001). High serum apolipoprotein AIV levels in renal transplant recipients.. PubMed. 55(2). 156–8. 4 indexed citations
5.
Kandoussi, A., C Cachera, Marc Hazzan, et al.. (1998). Apo(a) Phenotypes and Lp(a) Concentrations in Renal Transplant Patients. ˜The œNephron journals/Nephron journals. 80(2). 183–187. 5 indexed citations
6.
Kandoussi, A., Henri‐Joseph Parra, M Dracon, et al.. (1996). Apolipoprotein Al and Apolipoprotein B Containing Particle Analysis in Normolipidemic Hemodialyzed Patients: Evidence of Free Apolipoprotein E. American Journal of Nephrology. 16(4). 287–292. 3 indexed citations
7.
Kandoussi, A., C Cachera, Dominique Pagniez, Rachid Saı̈le, & A Tacquet. (1993). Quantification of beta 2-microglobulin and albumin in plasma and peritoneal dialysis fluid by a noncompetitive immunoenzymometric assay. Clinical Chemistry. 39(1). 93–96. 3 indexed citations
8.
Kandoussi, A., C Cachera, Dominique Pagniez, et al.. (1992). Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD. Kidney International. 42(2). 424–425. 37 indexed citations
9.
Kandoussi, A., C Cachera, Richard Reade, et al.. (1992). Apo AIV in plasma and dialysate fluid of CAPD patients: Comparison with other apolipoproteins. Nephrology Dialysis Transplantation. 7(10). 1026–1029. 12 indexed citations
11.
Saı̈le, Rachid, et al.. (1991). Quantification of serum amyloid P by enzyme-linked immunosorbent assay. Clinical Chemistry. 37(10). 1742–1745. 5 indexed citations
12.
Bard, Jean‐Marie, et al.. (1988). Effect of fenofibrate on apolipoprotein B containing lipoprotein particles.. PubMed. 255. 305–10. 1 indexed citations
13.
Puchois, Pascal, A. Kandoussi, P. Fievet, et al.. (1987). Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis. 68(1-2). 35–40. 284 indexed citations
14.
Koren, Eugen, Pascal Puchois, Petar Alaupovic, et al.. (1987). Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay.. Clinical Chemistry. 33(1). 38–43. 93 indexed citations
15.
Puchois, Pascal, A. Kandoussi, Patrick Duriez, et al.. (1986). Quantitative Determination of Human Plasma Apolipoprotein A-II by a Non Competitive Enzyme-Linked Immunosorbent Assay. Journal of Immunoassay. 7(4). 285–307. 18 indexed citations
16.
Fiévet, Catherine, et al.. (1986). Quantitation of human serum apolipoprotein B by enzyme immunoassay in excess antigen. Clinica Chimica Acta. 159(3). 269–278. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026